ArticleHuman vaccines & immunotherapeutics2025

Effective response to high-frequency and prolonged dupilumab therapy in severe refractory bullous pemphigoid: A case study.

Xiaoyun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.